retired staff member
Department of Dermatology, Erasmus Medical Centre, Rotterdam, Netherlands
Erasmus Medical Centre, Rotterdam, Netherlands
REET, Antwerpen, Belgium
Marianne De Maeseneer
General and Vascular Surgeon, °20.06.1955
Department of Dermatology, Erasmus Medical Centre,
Rotterdam, Netherlands (hospitality agreement)
Marianne De Maeseneer MD PhD retired from clinical work in June 2017, but remains connected to the section of Phlebology, at the Department of Dermatology at Eras¬mus MC in Rotterdam, Netherlands. As to clinical research she initially studied the problem of re¬current varicose veins after surgical treatment and this resulted in her PhD thesis, which she defended in 2005. Her academic interests have further focused on treatment strategies for varicose veins, prevention of recurrence, the use of duplex ultrasound before and after interven¬tion, management of post-thrombotic syndrome and anomalies of the in¬ferior vena cava.
She has authored and co-authored over 200 articles in peer-reviewed journals and several chapters in different textbooks, in English, Dutch and Spanish. She coordinated publication of the UIP (International Union of Phlebology) consensus document on duplex ultrasound reporting after varicose vein treatment (2011). She has served as Associate Editor for the European Journal for Vascular and Endovascular Surgery for the past 9 years, handling manuscripts about venous topics, and chaired the new 2022 ESVS Clinical Practice Guidelines on the management of chronic venous disease (published February 2022). She has been active as UIP Vice-President from 2013 till 2018 and as Director of the European Venous Forum (EVF) Hands-On Workshop from 2017 till 2019.
At present, she remains active in education and research, being committed in different international projects and (virtual) meetings in the field of phlebology.
mdmaesen@gmail.com
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose.
Sunday, September 17, 2023
6:30 PM – 8:30 PM US EDT
Sunday, September 17, 2023
6:30 PM – 8:30 PM US EDT
Global Abstracts - Monday 8:30 AM
Monday, September 18, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts - Monday 8:30 AM
Monday, September 18, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts - Monday 10:30 AM
Monday, September 18, 2023
10:30 AM – 12:00 PM US EDT
Global Abstracts - Monday 10:30 AM
Monday, September 18, 2023
10:30 AM – 12:00 PM US EDT
Global Abstracts - Monday 2:30 PM
Monday, September 18, 2023
2:30 PM – 4:00 PM US EDT
Global Abstracts - Monday 2:30 PM
Monday, September 18, 2023
2:30 PM – 4:00 PM US EDT
Global Abstracts -Tuesday 8:30 AM
Tuesday, September 19, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts -Tuesday 8:30 AM
Tuesday, September 19, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts - Tuesday 10:30 AM
Tuesday, September 19, 2023
10:30 AM – 12:00 PM US EDT
Global Abstracts - Tuesday 10:30 AM
Tuesday, September 19, 2023
10:30 AM – 12:00 PM US EDT
Global Abstracts - Tuesday 2:30 PM
Tuesday, September 19, 2023
2:30 PM – 4:00 PM US EDT
Global Abstracts - Tuesday 2:30 PM
Tuesday, September 19, 2023
2:30 PM – 4:00 PM US EDT
Standardization - Initial Venous Ultrasound Lower Extremity Veins
Tuesday, September 19, 2023
2:45 PM – 3:05 PM US EDT
Global Abstracts - Wednesday 8:30 AM
Wednesday, September 20, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts - Wednesday 8:30 AM
Wednesday, September 20, 2023
8:30 AM – 10:00 AM US EDT
Global Abstracts - Wednesday 10:30 AM
Wednesday, September 20, 2023
10:30 AM – 12:00 PM US EDT
Global Abstracts - Wednesday 10:30 AM
Wednesday, September 20, 2023
10:30 AM – 12:00 PM US EDT
Wednesday, September 20, 2023
3:21 PM – 3:40 PM US EDT